worldwide survey on clinical and anatomical factors driving the choice of transcatheter aortic valve prostheses

worldwide survey on clinical and anatomical factors driving the choice of transcatheter aortic valve prostheses

;Luigi Biasco;Luigi Biasco;Enrico Cerrato;Gregorio Tersalvi;Giovanni Pedrazzini;Giovanni Pedrazzini;Ben Wilkins;Francesco Faletra;Enrico Ferrari;Stefanos Demertzis;Gaetano Senatore;Angelo Di Leo;Ferdinando Varbella;Ole De Backer;Luis Nombela Franco
substance abuse treatment, prevention, and policy 2020 Vol. 7 pp. -
269
biasco2020frontiersworldwide

Abstract

Background: Following the success of the first human transcatheter aortic valve replacement (TAVR) in 2002, multiple transcatheter heart valves (THVs) have become available. However, guidelines or expert consensus on how to optimize THV choice according to patients' anatomical and clinical characteristics is missing. This survey-based study aimed to identify patient-specific characteristics deemed important in the choice of THV type.Methods and results: A web-based survey including 39 questions was completed by 71 experienced TAVR operators from 23 countries with a median TAVR volume of 88 procedures in the year prior to survey completion (IQR 61-180). The survey covered five topics: access, aortic annulus/leaflets, aortic root, left ventricular function and clinical characteristics. Factors with the most impact on THV choice were reported to be a calcified sinotubular junction, valve-in-valve procedure, annular dimension >575 mm2, femoral diameter ≤ 5.0 mm, low coronary ostia, calcification at the annular level and/or protruding into the left ventricular outflow tract, and need for post TAVR PCI. Also, in case of off-label use of THVs to treat bicuspid aortic valve disease and isolated aortic regurgitation, the choice of THV type was reported to be important.Conclusions: This survey-based study identifies key patient characteristics that impact THV selection. As such, we present a guide, based on current practice, of which THV types are best suited to these different patient-specific characteristics. A patient-tailored THV choice is likely to optimize TAVR outcomes.

Citation

ID: 148929
Ref Key: biasco2020frontiersworldwide
Use this key to autocite in SciMatic or Thesis Manager

References

Blockchain Verification

Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
148929
Unique Identifier:
10.3389/fcvm.2020.00038
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
5/5
Creates 1,000,000 NFT tokens for this article
Token Features:
  • ERC-1155 Standard NFT
  • 1 Million Supply per Article
  • Transferable via MetaMask
  • Permanent Blockchain Record
Blockchain QR Code
Scan with Saymatik Web3.0 Wallet

Saymatik Web3.0 Wallet